Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesal Gohil

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Cochrane Database of Systematic Reviews|December 4, 2019
Parent training programmes for managing infantile colicMorris Gordon, Jesal Gohil, Shel Sc Banks
AIDS (London, England)|January 28, 2026
The evolution of antiretroviral-associated drug-resistance mutations in an individual receiving dolutegravir/lamivudineJesal Gohil, Nicola E Mackie, Alan Winston
International Journal of STD & AIDS|August 20, 2024
BASHH standards for the management of sexual health in UK prisonsJesal Gohil, Sophie Ross, Katia Prime, et al.
International Journal of STD & AIDS|February 5, 2014
Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three yearsDornubari Lebari, Jesal Gohil, Lipsita Patnaik, et al.
BMC Public Health|January 11, 2020
Is the Philippines ready for HIV self-testing?Jesal Gohil, Emmanuel S Baja, Tyrone Reden Sy, et al.
The Lancet. Infectious Diseases|July 5, 2022
Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysisNicolò Girometti, Ruth Byrne, Margherita Bracchi, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO TrialMing Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV|May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trialMing J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Cochrane Database of Systematic Reviews|December 4, 2019
Parent training programmes for managing infantile colicMorris Gordon, Jesal Gohil, Shel Sc Banks
AIDS (London, England)|January 28, 2026
The evolution of antiretroviral-associated drug-resistance mutations in an individual receiving dolutegravir/lamivudineJesal Gohil, Nicola E Mackie, Alan Winston
International Journal of STD & AIDS|August 20, 2024
BASHH standards for the management of sexual health in UK prisonsJesal Gohil, Sophie Ross, Katia Prime, et al.
International Journal of STD & AIDS|February 5, 2014
Isolated penile Kaposi's sarcoma in a HIV-positive patient stable on treatment for three yearsDornubari Lebari, Jesal Gohil, Lipsita Patnaik, et al.
BMC Public Health|January 11, 2020
Is the Philippines ready for HIV self-testing?Jesal Gohil, Emmanuel S Baja, Tyrone Reden Sy, et al.
The Lancet. Infectious Diseases|July 5, 2022
Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysisNicolò Girometti, Ruth Byrne, Margherita Bracchi, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO TrialMing Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV|May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trialMing J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Pageof 1